World News – Page 2 – Research in Toxicology

The Global Persistence of ‘Forever Chemicals’

January 3, 2026January 18, 2026admin

From non-stick frying pans to water-resistant outdoor gear, PFAS (per- and polyfluoroalkyl substances) have become an invisible staple of modern manufacturing. These synthetic compounds are prized for their ability to repel oil and water, but their greatest industrial strength is also a significant environmental threat. Because they do not break down naturally, they have earned the notorious nickname ‘forever chemicals’.

The scale of the issue is truly international. PFAS are highly mobile, travelling through water systems and atmosphere to reach even the most remote corners of the globe. The European Environment Agency has highlighted that these substances accumulate in the human body and the environment, leading to long-term exposure risks that transcend national borders.

Research into the health impacts of PFAS is ongoing worldwide. High levels of exposure have been linked to liver damage, thyroid disease, and developmental issues. Consequently, international bodies like the OECD are working to coordinate the risk assessment and management of these chemicals on a global scale.

As the world moves towards a more sustainable future, the transition to PFAS-free alternatives is becoming a priority for manufacturers and consumers alike. By choosing products with transparent chemical credentials, we can all contribute to reducing the global burden of these persistent pollutants.

Unauthorised login attempts

March 25, 2025January 23, 2026admin

That means this site has impact and that it is a good site. Enough said about that.

Molecular Decoys: The Dawn of Synthetic Antivenom

February 23, 2024January 23, 2026admin

Molecular Decoys: The Dawn of Synthetic Antivenom

For over a century, the clinical management of snakebite envenoming has remained tethered to the Victorian era. The reliance on heterologous, horse-derived sera presents significant limitations: batch inconsistency, a substantial risk of anaphylaxis, and a lack of technological innovation. However, the development of 95Mat5, a humanised recombinant monoclonal antibody, signals a fundamental paradigm shift in toxin neutralisation.

The lethality of elapid envenomation—specifically within the Naja (cobra) and Ophiophagus (king cobra) genera—is driven primarily by long-chain α-neurotoxins (LCNs). These potent molecules bind to nerve receptors, inducing rapid respiratory paralysis. 95Mat5 utilises a sophisticated biomimetic mechanism to counteract this pathology. By replicating the binding interface of the nicotinic acetylcholine receptor (nAChR), the antibody acts as a molecular decoy, effectively diverting toxins away from the victim’s neuromuscular junctions.

Crucially, 95Mat5 demonstrates broad-spectrum efficacy. In preclinical trials, it successfully neutralised whole venom from diverse species, including the Monocled Cobra (Naja kaouthia), Spitting Cobras, and the King Cobra (Ophiophagus hannah). This cross-reactivity is vital, addressing the high variability often found in venom compositions.

This discovery validates the feasibility of synthetic, ‘universal’ antivenoms—the field’s long-sought ‘Holy Grail’. We are arguably witnessing the end of the equine era in venomology, moving toward consistent, laboratory-synthesised therapeutics capable of mitigating lethal toxin variants across distinct genus lines.

Khalek, I. et al. (2024) ‘Synthetic development of a broadly neutralizing antibody against snake venom long-chain α-neurotoxins’
Source Access